No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
- 2.1700
- -0.0700-3.13%
Close Jul 2 16:00 ET
- 2.1600
- -0.0100-0.46%
Post 19:11 ET
2.93MMarket Cap-19P/E (TTM)
2.2700High2.1501Low18.57KVolume2.2300Open2.2400Pre Close40.49KTurnover1.38%Turnover RatioLossP/E (Static)1.35MShares44.800052wk High-2.21P/B2.91MFloat Cap2.050152wk Low--Dividend TTM1.34MShs Float130156.1979Historical High--Div YieldTTM5.35%Amplitude2.0500Historical Low2.1800Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Eyenovia Shares Are Trading Higher. The Company Announced That It Commenced Activities With NovaBay Pharmaceuticals to Promote Eye Care Products to Ophthalmic Surgery Centers
NovaBay and Eyenovia Begin Co-Promotion of Eyecare Products to Ophthalmic Surgery Centers
NovaBay Pharmaceuticals, Inc. (NYSE:NBY), a company developing and commercializing high-quality eyecare products, and Eyenovia, Inc. (NASDAQ:EYEN), a commercial-stage ophthalmic company with two FDA-a
NovaBay Files to Offer Common Stock and Warrants
NovaBay Files Registration Statement on Behalf of Selling Shareholders
NovaBay Pharmaceuticals (NBY) on late Thursday filed a registration statement for an offering by certain selling shareholders of up to 298,355 common shares. The prospectus covers the sale of common s
NovaBay Files to Sell 298,355 Shares of Common Stock for Holders
Express News | NovaBay Pharmaceuticals Announces Warrant Exercise At Reduced Price Of $2.50; 90,381 Shares Exercised, Generating $225,952 In Gross Proceeds
Comments
$NovaBay Pharmaceuticals(NBY.US$ anyone know why nby is showing up as suspended?
1
$NovaBay Pharmaceuticals(NBY.US$ NovaBay Pharmaceuticals Inc: Announces a 1-for-35 Reverse Stock Split
3
2
$NovaBay Pharmaceuticals(NBY.US$
NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
NovaBay Pharmaceuticals announced the approval of all proposals at its 2024 Annual Meeting, including a 1-for-35 reverse stock split. This decision aims to align with the NYSE American's listing standards and enhance stock marketability and liquidity. The reverse stock split will be effective on May 30, 2024, and shares ...
NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
NovaBay Pharmaceuticals announced the approval of all proposals at its 2024 Annual Meeting, including a 1-for-35 reverse stock split. This decision aims to align with the NYSE American's listing standards and enhance stock marketability and liquidity. The reverse stock split will be effective on May 30, 2024, and shares ...
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
WS_gains : Reverse split